• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP1 炎性小体通路在皮肤鳞状细胞癌中被沉默。

The NLRP1 Inflammasome Pathway Is Silenced in Cutaneous Squamous Cell Carcinoma.

机构信息

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Switzerland.

Institute for Molecular Health Sciences, Department of Biology, ETH Zürich, Zurich, Switzerland.

出版信息

J Invest Dermatol. 2019 Aug;139(8):1788-1797.e6. doi: 10.1016/j.jid.2019.01.025. Epub 2019 Feb 7.

DOI:10.1016/j.jid.2019.01.025
PMID:30738816
Abstract

The inflammasome protein NLRP1 is an important innate immune sensor in human keratinocytes, and, together with ASC and caspase-1, it mediates the activation and secretion of the proinflammatory cytokines IL-1β and IL-18. These cytokines and inflammasomes can have partly opposing roles during tumorigenesis in mice. In contrast, ASC expression is impaired in different types of cancer in humans. In this study, we analyzed inflammasome activation and expression of inflammasome proteins, including their downstream cytokines, in squamous cell carcinomas, a type of nonmelanoma skin cancer derived from keratinocytes. We assessed mRNA and protein levels in human primary keratinocytes and skin carcinoma-derived SCC cell lines and detected a strong down-regulation of expression of NLRP1 inflammasome components, as well as reduced expression of the proinflammatory cytokines proIL-1β and proIL-1α. Protein levels of NLRP1, ASC, caspase-1, and proIL-1β were reduced in patient-derived SCC biopsy samples compared with healthy skin. Furthermore, the results suggest that expression of PYCARD (ASC), CASP1, IL1B, and NLRP1 is silenced by methylation in SCC cell lines. In conclusion, the down-regulation of the inflammasome pathway in SCCs might favor late tumor development in human skin.

摘要

NLRP1 炎性小体蛋白是人类角质形成细胞中重要的先天免疫传感器,与 ASC 和半胱天冬酶-1 一起,介导促炎细胞因子 IL-1β 和 IL-18 的激活和分泌。这些细胞因子和炎性小体在小鼠肿瘤发生过程中可能具有部分相反的作用。相比之下,在人类的不同类型癌症中,ASC 的表达受损。在这项研究中,我们分析了炎性小体的激活和炎性小体蛋白的表达,包括它们的下游细胞因子,在鳞状细胞癌中,这是一种源自角质形成细胞的非黑色素瘤皮肤癌。我们评估了人原代角质形成细胞和皮肤癌衍生的 SCC 细胞系中的 mRNA 和蛋白质水平,并检测到 NLRP1 炎性小体成分的表达强烈下调,以及促炎细胞因子 proIL-1β 和 proIL-1α 的表达降低。与健康皮肤相比,来自患者的 SCC 活检样本中 NLRP1、ASC、半胱天冬酶-1 和 proIL-1β 的蛋白水平降低。此外,结果表明 PYCARD(ASC)、CASP1、IL1B 和 NLRP1 的表达在 SCC 细胞系中被甲基化沉默。总之,SCC 中炎性小体通路的下调可能有利于人类皮肤中晚期肿瘤的发展。

相似文献

1
The NLRP1 Inflammasome Pathway Is Silenced in Cutaneous Squamous Cell Carcinoma.NLRP1 炎性小体通路在皮肤鳞状细胞癌中被沉默。
J Invest Dermatol. 2019 Aug;139(8):1788-1797.e6. doi: 10.1016/j.jid.2019.01.025. Epub 2019 Feb 7.
2
The NLRP1 Inflammasome in Human Skin and Beyond.NLRP1 炎性小体在人类皮肤及其他组织中的作用。
Int J Mol Sci. 2020 Jul 6;21(13):4788. doi: 10.3390/ijms21134788.
3
Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation.胚系 NLRP1 突变通过炎症小体激活导致皮肤炎症和癌症易感性综合征。
Cell. 2016 Sep 22;167(1):187-202.e17. doi: 10.1016/j.cell.2016.09.001.
4
NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development.NLRP1 在皮肤鳞状细胞癌中的作用:炎症小体在癌症发展中的复杂作用的一个例子。
Int J Mol Sci. 2022 Oct 14;23(20):12308. doi: 10.3390/ijms232012308.
5
NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma.NLRP1通过增强炎性小体激活和抑制转移性黑色素瘤中的细胞凋亡来促进肿瘤生长。
Oncogene. 2017 Jul 6;36(27):3820-3830. doi: 10.1038/onc.2017.26. Epub 2017 Mar 6.
6
Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.组织特异性炎症小体衔接蛋白 ASC 在调控上皮性皮肤癌发生中的相反作用。
Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18384-9. doi: 10.1073/pnas.1209171109. Epub 2012 Oct 22.
7
Nlrp1 inflammasome is downregulated in trauma patients.Nlrp1炎性小体在创伤患者中表达下调。
J Mol Med (Berl). 2015 Dec;93(12):1391-400. doi: 10.1007/s00109-015-1320-0. Epub 2015 Aug 2.
8
High p62 expression suppresses the NLRP1 inflammasome and increases stress resistance in cutaneous SCC cells.高 p62 表达抑制 NLRP1 炎性小体并增加皮肤 SCC 细胞的应激抗性。
Cell Death Dis. 2022 Dec 29;13(12):1077. doi: 10.1038/s41419-022-05530-0.
9
Expression of inflammasome proteins and inflammasome activation occurs in human, but not in murine keratinocytes.人角质形成细胞中存在炎症小体蛋白的表达和炎症小体激活,而鼠角质形成细胞中则不存在。
Cell Death Dis. 2018 Jan 18;9(2):24. doi: 10.1038/s41419-017-0009-4.
10
Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.增强的NLRP3、NLRP1、NLRC4和AIM2炎性小体介导的甲状腺滤泡细胞细胞因子分泌和焦亡与自身免疫性甲状腺炎相关。
Front Immunol. 2018 Jun 4;9:1197. doi: 10.3389/fimmu.2018.01197. eCollection 2018.

引用本文的文献

1
p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.p62信使核糖核酸通过微小核糖核酸-34a-5p抑制皮肤鳞状细胞癌细胞中NLRP1的表达。
Cell Death Dis. 2025 Jul 1;16(1):465. doi: 10.1038/s41419-025-07785-9.
2
The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan-Cancer Analysis.NLRP1成为多种癌症类型中一个有前景的治疗靶点和预后生物标志物:一项全面的泛癌分析。
Cancer Med. 2025 Apr;14(8):e70836. doi: 10.1002/cam4.70836.
3
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer.
炎症小体相关固有免疫受体在癌症中的作用
Immune Netw. 2024 Oct 21;24(5):e38. doi: 10.4110/in.2024.24.e38. eCollection 2024 Oct.
4
NLRP1 inhibits lung adenocarcinoma growth through mediating mitochondrial dysregulation in an inflammasome-independent manner.NLRP1 通过以炎症小体非依赖的方式调控线粒体功能障碍抑制肺腺癌生长。
Braz J Med Biol Res. 2024 Sep 6;57:e13885. doi: 10.1590/1414-431X2024e13885. eCollection 2024.
5
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study.转移性皮肤鳞状细胞癌的分子和组织病理学特征:一项病例对照研究。
Cancers (Basel). 2024 Jun 15;16(12):2233. doi: 10.3390/cancers16122233.
6
Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome.钾离子外流驱动的人源 NLRP1 炎症小体激活的机制基础。
Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2309579121. doi: 10.1073/pnas.2309579121. Epub 2024 Jan 4.
7
Development and validation of a CECT-based radiomics model for predicting IL1B expression and prognosis of head and neck squamous cell carcinoma.基于CT增强扫描的头颈部鳞状细胞癌IL1B表达及预后预测的影像组学模型的建立与验证
Front Oncol. 2023 Mar 10;13:1121485. doi: 10.3389/fonc.2023.1121485. eCollection 2023.
8
The NLRP1 inflammasome in skin diseases.NLRP1 炎性小体与皮肤疾病。
Front Immunol. 2023 Feb 23;14:1111611. doi: 10.3389/fimmu.2023.1111611. eCollection 2023.
9
High p62 expression suppresses the NLRP1 inflammasome and increases stress resistance in cutaneous SCC cells.高 p62 表达抑制 NLRP1 炎性小体并增加皮肤 SCC 细胞的应激抗性。
Cell Death Dis. 2022 Dec 29;13(12):1077. doi: 10.1038/s41419-022-05530-0.
10
NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development.NLRP1 在皮肤鳞状细胞癌中的作用:炎症小体在癌症发展中的复杂作用的一个例子。
Int J Mol Sci. 2022 Oct 14;23(20):12308. doi: 10.3390/ijms232012308.